RaƱola, Nestor L.
HRN: 12-47-05 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/25/2023
CEFTAZIDIME 1GM (VIAL)
08/25/2023
09/21/2023
IV
1 Gram
Q 8 Hours
Cap Mr
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes